These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1242128)

  • 1. Effects of CB-154 (2-Br-alpha-ergocryptine) on prolactin and growth hormone release in an acromegalic patient with galactorrhea.
    Ueda G; Sato Y; Yamasaki M; Shioji T; Aono T
    Endocrinol Jpn; 1975 Jun; 22(3):265-8. PubMed ID: 1242128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Aono T; Shioji T; Kohno M; Ueda G; Kurachi K
    Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ; Geiger W; Schulz KD; Lose KH
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA; Roland R; Lequin RM
    Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome.
    Corenblum B; Taylor PJ
    Fertil Steril; 1978 Oct; 30(4):388-92. PubMed ID: 581377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly and galactorrhea-amenorrhea with two pituitary adenomas secreting growth hormone or prolactin. A case report.
    Tolis G; Bertrand G; Carpenter S; McKenzie JM
    Ann Intern Med; 1978 Sep; 89(3):345-8. PubMed ID: 686546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG
    South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs that affect the breast and lactation.
    Dickey RP; Stone SC
    Clin Obstet Gynecol; 1975 Jun; 18(2):95-111. PubMed ID: 1095275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lergotrile on galactorrhea and gonadotropin secretion.
    Cleary RE; Crabtree R; Lemberger L
    J Clin Endocrinol Metab; 1975 May; 40(5):830-3. PubMed ID: 165221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
    Wiebe RH; Hammond CB; Handwerger S
    Fertil Steril; 1977 Apr; 28(4):426-33. PubMed ID: 321260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
    Netter A; Netter AL; Gorins A
    Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.